false 0000806517 0000806517 2024-05-28 2024-05-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 28, 2024

 

 

PSYCHEMEDICS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware  1-13738  58-1701987
(State or Other Jurisdiction  (Commission File Number)  (I.R.S. Employer
of Incorporation)     Identification No.)

 

5220 Spring Valley Road, Suite 230, Dallas, TX  75254
(Address of Principal Executive Offices)  (Zip Code)

 

(800) 527-7424

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class Trading Symbol(s) Name of each exchange on which registered
Common stock. $0.005 par value PMD The Nasdaq Stock Market, LLC.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

ITEM 1.02. TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT

 

On May 28, 2024 Psychemedics corporation (the “Company”) entered into a Lease Termination Agreement with Culver City/Hannum, LLC, a California limited liability company (“Landlord”) for certain premises located at 5750 Hannum Avenue, Culver City, CA 90230 (the “Lease Termination Agreement”). The Lease Termination Agreement provides that that certain Standard Industrial/Commercial Multi-Tenant Lease - Net dated as of July 29, 2019 by and between the Company and Landlord (as the same may have been amended, the “Lease”), will terminate effective June 30, 2024.

 

The consideration payable by the Company for Landlord’s agreement to enter into the Lease Termination Agreement and accelerate the expiration date of the term of the Lease to June 30, 2024, is approximately $110 thousand. The Company expects to realize net cost savings from rightsizing of facility costs of approximately $250 thousand for the balance of the original lease term from what we would otherwise have paid.

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PSYCHEMEDICS CORPORATION
Dated: June 3, 2024     
     
     
  By: /s/ Daniella Mehalik
    Daniella Mehalik,
    Vice President of Finance
     

 

v3.24.1.1.u2
Cover
May 28, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 28, 2024
Entity File Number 1-13738
Entity Registrant Name PSYCHEMEDICS CORPORATION
Entity Central Index Key 0000806517
Entity Tax Identification Number 58-1701987
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 5220 Spring Valley Road
Entity Address, Address Line Two Suite 230
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75254
City Area Code (800)
Local Phone Number 527-7424
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock. $0.005 par value
Trading Symbol PMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Psychemedics (NASDAQ:PMD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Psychemedics.
Psychemedics (NASDAQ:PMD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Psychemedics.